- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7373
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Rethinking medulloblastoma from a targeted therapeutics perspective ; day:5 ; month:6 ; year:2018 ; pages:1-8
Journal of neuro-oncology ; (5.6.2018), 1-8
- Urheber
-
Hashimoto, Yuuri
- Beteiligte Personen und Organisationen
-
Penas-Prado, Marta
Zhou, Shouhao
Wei, Jun
Khatua, Soumen
Hodges, Tiffany R.
Sanai, Nader
Xiu, Joanne
Gatalica, Zoran
Kim, Lyndon
Kesari, Santosh
Rao, Ganesh
Spetzler, David
Heimberger, Amy
SpringerLink (Online service)
- DOI
-
10.1007/s11060-018-2917-2
- URN
-
urn:nbn:de:101:1-2018081119483811366660
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hashimoto, Yuuri
- Penas-Prado, Marta
- Zhou, Shouhao
- Wei, Jun
- Khatua, Soumen
- Hodges, Tiffany R.
- Sanai, Nader
- Xiu, Joanne
- Gatalica, Zoran
- Kim, Lyndon
- Kesari, Santosh
- Rao, Ganesh
- Spetzler, David
- Heimberger, Amy
- SpringerLink (Online service)
Ähnliche Objekte (12)
Melanoma : Biologically Targeted Therapeutics
Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma
Plasmonic Material Engineering for Targeted Therapeutics
Emerging Targeted Therapeutics for Genetic Subtypes of Parkinsonism
Lysosome‐Targeted Bifunctional Therapeutics Induce Autodynamic Cancer Therapy
Rethinking Photography: A Historical Perspective
Oligonucleotide therapeutics in sports? An antidoping perspective
Trastuzumab Sensitizes Ovarian Cancer Cells to EGFR-targeted Therapeutics
Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP
Progress and challenges towards targeted delivery of cancer therapeutics
Medulloblastoma cerebelli
Intramedullary injury combined with osteoporosis therapeutics regulates targeted local osteogenesis
Melanoma : Biologically Targeted Therapeutics
Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma
Plasmonic Material Engineering for Targeted Therapeutics
Emerging Targeted Therapeutics for Genetic Subtypes of Parkinsonism
Lysosome‐Targeted Bifunctional Therapeutics Induce Autodynamic Cancer Therapy
Rethinking Photography: A Historical Perspective
Oligonucleotide therapeutics in sports? An antidoping perspective
Trastuzumab Sensitizes Ovarian Cancer Cells to EGFR-targeted Therapeutics
Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP
Progress and challenges towards targeted delivery of cancer therapeutics
Medulloblastoma cerebelli
Intramedullary injury combined with osteoporosis therapeutics regulates targeted local osteogenesis
Melanoma : Biologically Targeted Therapeutics
Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma
Plasmonic Material Engineering for Targeted Therapeutics
Emerging Targeted Therapeutics for Genetic Subtypes of Parkinsonism
Lysosome‐Targeted Bifunctional Therapeutics Induce Autodynamic Cancer Therapy
Rethinking Photography: A Historical Perspective
Oligonucleotide therapeutics in sports? An antidoping perspective
Trastuzumab Sensitizes Ovarian Cancer Cells to EGFR-targeted Therapeutics
Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP
Progress and challenges towards targeted delivery of cancer therapeutics
Medulloblastoma cerebelli